CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Role of Geriatric Assessment in Hematopoietic Stem Cell Transplant and Cellular Therapies.
Role of Geriatric Assessment in Hematopoietic Stem Cell Transplant and Cellular Therapies.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
血液系统恶性肿瘤在老年人中常见,而这一群体在治疗中面临独特挑战。尽管造血干细胞移植和 CAR-T 疗法为患有高危疾病的老年人提供了有前景、可能治愈且持久的治疗选择,但其有效性可能受到个体整体健康状况和耐受强化治疗能力的限制。该人群中的传统体能评估往往无法应对衰老的复杂性。相反,老年综合评估提供了对老年人多个领域健康状况的更全面评价,包括身体健康、认知功能、心理健康、营养、合并症、多重用药和社会支持。这种整体性方法有助于更好地理解患者的恢复力,并促进及时调整干预措施,从而可能改善生存结局和生活质量。本综述旨在探讨当前关于将老年综合评估整合到老年患者造血干细胞移植和 CAR-T 疗法优化中的证据,以及各种照护模式、其潜力和未来方向。
Hematological malignancies are common among older adults, a group that faces unique challenges in treatment. While hematopoietic stem cell transplantation and CAR-T therapy offer promising, potentially curative and durable treatment options for older adults with high-risk diseases, their effectiveness can be limited by the individual's overall health and ability to tolerate intensive treatments. Conventional fitness assessments in this population often fall short in addressing the complexities of aging.
Conversely, geriatric assessment provides a more comprehensive evaluation of an older adult's health across multiple domains, including physical health, cognitive function, mental health, nutrition, comorbidities, polypharmacy, and social support. This holistic approach helps to better understand the patient's resilience and facilitate timely adjustments to interventions, potentially improving both survival outcomes and quality of life.
This review aims to explore the current evidence on integrating geriatric assessments into the optimization of older patients for hematopoietic stem cell transplantation and CAR-T therapy, along with various care models, their potential, and future directions.
MEMBER ACCOUNT
登录成功会直接打开下一页。